DailyStocks Stock Article Search

https://seekingalpha.com/article/4666707-2-great-preferred-stocks-for-a-retirement-dream?source=feed Feb 02, 2024 - With a history of low default rates, today’s preferreds carry much higher credit quality. Check out 2 great preferred stocks for a Retirement Dream. 0

https://www.wired.com/story/cheap-insulin-biosimilar-rbio/ Feb 02, 2024 - Houston-based rBIO has invented a new process to churn out insulin at higher yields using custom-made bacteria. 0

https://seekingalpha.com/article/4667015-ffc-portfolio-assets-appear-overpriced-some-profit-taking-could-be-smart?source=feed_tag_etf_portfolio_strategy Feb 02, 2024 - FFC has suffered losses over the past two years due to high leverage and cuts in distribution. Find out my recommendation on the fund. 0

https://seekingalpha.com/article/4666991-quickly-out-of-gate?source=feed_all_articles Feb 01, 2024 - The race into 2024 has begun, and the U.S. market is off to a quick start. The S&P 500 jumped out of the gates by +1.6% 0

https://seekingalpha.com/article/4666971-soxq-it-may-finally-be-time-for-reversal?source=feed_tag_etf_portfolio_strategy Feb 01, 2024 - Invesco PHLX Semiconductor ETF offers comprehensive exposure to the semiconductor segment of the technology sector. Find out my recommendation on SOXQ fund. 0

https://www.zacks.com/commentary/2219797/steel-producer-breaks-out-amid-powerful-uptrend?cid=CS-ZC-FT-investment_ideas-2219797 Feb 01, 2024 - This leading steel stock is hitting all-time highs on above-average volume. 0

https://www.zacks.com/stock/news/2219741/what-makes-azz-azz-a-strong-momentum-stock-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2219741 Feb 01, 2024 - Does AZZ (AZZ) have what it takes to be a top stock pick for momentum investors? Let's find out. 0

https://seekingalpha.com/article/4666690-navigating-day-one-biopharmaceuticals-financial-health-and-clinical-prospects?source=feed_tag_editors_picks Feb 01, 2024 - Day One Biopharmaceuticals is a leader in pediatric oncology, with focus on addressing unmet needs of pediatric cancer patients. Find out why DAWN stock is a Buy. 0

https://www.zacks.com/stock/news/2219570/analysts-estimate-silvercorp-svm-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219570 Feb 01, 2024 - Silvercorp (SVM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2219574/analysts-estimate-kellanova-k-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219574 Feb 01, 2024 - Kellanova (K) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0